This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Gennext Technologies, Inc., Glycoscientific LLC, University of Georgia Research Foundation Inc. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2024
Title: Innovations by Ronald Carl Orlando
Introduction
Ronald Carl Orlando is a notable inventor based in Athens, GA (US), recognized for his contributions to the field of biopharmaceuticals. He holds a total of five patents, showcasing his innovative approach to biomolecular analysis and therapeutic drug development.
Latest Patents
Orlando's latest patents include "Radical dosimetry methods for in vivo hydroxyl radical protein foot-printing - Flash Photo-Oxidation Device" and "Higher Order Structural Analysis." These inventions focus on the higher order structural analysis of biomolecules, which is crucial for understanding how biomolecules interact within living systems. The analysis of biomolecular higher order structure (HOS) is essential, especially for biotherapeutics, as their therapeutic properties are closely linked to their HOS. Orlando's inventions provide new methodologies for determining biopharmaceutical HOS and associated conformations, addressing the growing demand for improved analytical techniques in the biopharmaceutical industry.
Career Highlights
Throughout his career, Orlando has worked with various companies, including Gennext Technologies, Inc. and Glycoscientific LLC. His work has significantly impacted the field of biopharmaceuticals, particularly in the development of analytical methods for biomolecular structures.
Collaborations
Orlando has collaborated with notable individuals in his field, including Scot Randy Weinberger and Joshua Shane Sharp. These collaborations have further enhanced his research and contributions to the industry.
Conclusion
Ronald Carl Orlando's innovative work in the analysis of biomolecular structures has made a significant impact on the biopharmaceutical industry. His patents and collaborations reflect his commitment to advancing the field and addressing the analytical needs of biotherapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
